$STAR
Strides Pharma Science Limited · NSE · Healthcare
- Market cap
- 108.65B
- Volume
- 2.62M
- P/E
- 15.92
- Day range
- 1045.00 – 1187.60
- 52w range
- 768.65 – 1231.00
- Analyst target
- 1338.67
AI Summary
Generating a unique summary for STAR.NS…
AI-generated for information only — not investment advice.
Share this ticker
$STAR +11.25% at 1178.80 Rakesh Jhunjhunwala and 0 other tracked billionaires hold it. $JNJ $NTRA $LLY https://billionairestrading.com/stocks/STAR.NS
Company summary
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Institutional ownership
Institutions hold 29.59% · insiders 30.78% · 62 institutions
No institutional filings available for this ticker.
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| Life Insurance Corpoation of India | Institution- Corporation | — | 3.74M | 2024-10-24 |
Analyst ratings
Consensus score — (1 = strong buy, 5 = sell) · mean target 1338.67
No recent analyst actions.
Earnings
Next report: not scheduled
No earnings history available.
SEC filings
No filings indexed for this ticker.
Latest STAR.NS news
- Strides Pharma Science Ltd (BOM:532531) Q4 2026 Earnings Call Highlights: Record EBITDA and ...
Strides Pharma Science Ltd (BOM:532531) reports robust revenue growth and strategic investments, despite challenges in the US market.
Wed, 17 Jun 2026 22:20:41 +0000
- Strides Pharma Science Ltd (BOM:532531) (Q1 FY27) Earnings Call Highlights: Ex-US Growth Drives ...
Strides Pharma Science Ltd (BOM:532531) posts strong Q1 FY27 results with 17% ex-US growth and 57% PAT jump, while navigating US market softness and geopolitical headwinds.
Tue, 04 Aug 2026 01:04:50 +0000
- Kenox Enters into Strategic Product Development Partnership with Strides
Strides Pharma Science Ltd today announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a strategic product development partnership with Kenox Pharmaceuticals Inc. ("Kenox"), a fast-growing contract development and manufacturing company specializing in Orally Inhaled and Nasal Drug Products (OINDPs).
Tue, 09 Sep 2025 16:47:00 +0000